COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/V0QNfi33eA #ACR19 @RheumNow plenary#2729 #ACRbest https://t.co/VVkEfLpHzs
Links:
Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a …
http://ow.ly/KUY850x3EfF
Nov-12-2019
